Literature DB >> 2064381

Antiarrhythmic drugs.

R L Woosley1.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 2064381     DOI： 10.1146/annurev.pa.31.040191.002235

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN： 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  7 in total

1.  Blockade by antiarrhythmic drugs of glibenclamide-sensitive K+ channels in Xenopus oocytes.

Authors:  H Sakuta; K Okamoto; Y Watanabe
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

Review 2.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

Review 3.  Structure, function and expression of voltage-dependent sodium channels.

Authors:  R G Kallen; S A Cohen; R L Barchi
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

4.  The effects of flecainide on ATP-sensitive K(+) channels in pig urethral myocytes.

Authors:  T Yunoki; N Teramoto; S Naito; Y Ito
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

5.  Cardiac electrophysiologic and antiarrhythmic actions of a pavine alkaloid derivative, O-methyl-neocaryachine, in rat heart.

Authors:  Gwo-Jyh Chang; Ming-Jai Su; Li-Man Hung; Shoei-Sheng Lee
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

Review 6.  Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Authors:  H M Bryson; K J Palmer; H D Langtry; A Fitton
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

7.  Molecular and functional diversity of cloned cardiac potassium channels.

Authors:  P B Bennett; S Po; D J Snyders; M M Tamkun
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.